VELA Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,416
Closed -$394K 156
2024
Q4
$394K Hold
4,416
0.11% 142
2024
Q3
$370K Sell
4,416
-11,768
-73% -$928K 0.11% 143
2024
Q2
$1.25M Hold
16,184
0.39% 93
2024
Q1
$1.11M Hold
16,184
0.38% 90
2023
Q4
$936K Sell
16,184
-2,076
-11% -$111K 0.36% 96
2023
Q3
$964K Hold
18,260
0.42% 83
2023
Q2
$988K Sell
18,260
-1,639
-8% -$85.6K 0.46% 82
2023
Q1
$996K Buy
19,899
+4,295
+28% +$202K 0.45% 77
2022
Q4
$722K Sell
15,604
-366
-2% -$15.8K 0.36% 86
2022
Q3
$619K Buy
15,970
+4,416
+38% +$177K 0.35% 85
2022
Q2
$431K Buy
11,554
+1,263
+12% +$51.4K 0.25% 107
2022
Q1
$456K Hold
10,291
0.29% 95
2021
Q4
$437K Buy
+10,291
New +$432K 0.29% 100

Other funds holding BSX

VELA Investment Management's BSX Position: Q1 2025 in Review

VELA Investment Management sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 4,416 shares — an estimated $394K sold.

VELA Investment Management first reported a position in BSX in Q4 2021 and held it in 13 quarters. The position peaked at $1.25M in Q2 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • VELA Investment Management reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • VELA Investment Management sold 4,416 Boston Scientific shares in Q1 2025, an estimated $394K.
  • VELA Investment Management first reported a position in Boston Scientific in Q4 2021 and held it in 13 quarters.
  • VELA Investment Management's Boston Scientific position peaked at $1.25M in Q2 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on VELA Investment Management's 13F filing for Q1 2025, filed 29 Apr 2025.